Bioequivalence of Two Fixed-dose Combination Tablets Containing Estradiol and Nomegestrol Acetate

PHASE1WithdrawnINTERVENTIONAL

Timeline

Start Date

October 31, 2019

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions

Bioequivalence

Interventions

DRUG

Estradiol 1.5 mg/nomegestrol acetate 2.5 mg (Reference Product)

Marketed Drug

DRUG

Estradiol 1.5 mg/nomegestrol acetate 2.5 mg (Test Product)

Investigational Medicinal Product

Trial Locations (1)

Investigacíon Farmacológica y Biofarmacéutica (IFaB), S.A.P.I. de C.V., Mexico City